51Relationship between ABCF2 expression and response to chemotherapy or prognosis in clear cell adenocarcinoma of the ovary
Tsuda H, Ito K, Yaegashi N, Hirasawa A, Sudo T, Kita T, Terai Y, Kigawa J, Sugiyama T, Aoki D
2010Int J Gynecol Cancer 20794-797
52Lymph node metastasis in grossly stage I and II epithelial ovarian cancer
Nomura H, Tsuda H, Susumu N, Fujii T, Banno K, Kataoka F, Suzuki A, Chiyoda T, Aoki D
2010Int J Gynecol Cancer 20341-345
53Less impact of adjuvant chemotherapy for stage I clear cell carcinoma of the ovary : a retrospective Japan Clear Cell Carcinoma Study
Takano M, Sugiyama T, Yaegashi N, Sagae S, Kuzuya K, Udagawa Y, Tsuda H, Suzuki M, Kigawa J, Goto T, Tsuda H, Moriya T, Kikuchi Y
2010Int J Gynecol Cancer 201506-1510
54Amplification of GNAS may be an independent, qualitative and reproducible biomarker to predict progression free survival in epithelial ovarian cancer
Tominaga E, Tsuda H, Arao T, Nishimura S, Takano M, Kataoka F, Nomura H, Hirasawa A, Aoki D, Nishio K
2010Gynecol Oncol 118160-166
55Overexpression of cofilin1 can predict the progression free survival on epithelial ovarian cancer
Nishimura S, Tsuda H, Kataoka F, Arao T, Nomura H, Chiyoda T, Tanaka H, Susumu N, Nishio K, Aoki D
2011Human Pathol 4516-519
56Validation of the histological grading for ovarian clear-cell adenocarcinoma : a retrospective multi-institutional study of Japan Clear Cell Carcinoma Study Group
Yamamoto S, Kasajima A, Takano M, Yaegashi N, Suzuki M, Kuzuya K, Kigawa J, Tsuda H, Kurachi H, Kikuchi Y, Sugiyama T, Tsuda H, Moriya T
2011Int J Gynecol Pathol 3029-138
57The expression of hypoxia inducible 2 （HIG2） protein in the uterine cancer
Nishimura S, Tsuda H, Nomura H, Kataoka F, Chiyoda T, Tanaka H, Tanaka K, Susumu N, Aoki D
2011Eur J Gynaecol Oncol XXXII146-149
58The chemosensitivity of nodal metastases in recurrent epithelial ovarian cancer
Kataoka F, Tsuda H, Nomura H, Chiyoda T, Tominaga E, Suzuki A, Susumu N, Aoki D
2011Eur J Gynaecol Oncol XXXII160-163
59Retrospective study comparing irinotecan and pegylated liposomal doxorubcin in treatment of recurrent platinum refractory / resistant epithelial ovarian cancer
Nomura H, Tsuda H, Chiyoda T, Kataoka F, Susumu N, Aoki D
2012Eur J Gynaecol Oncol 3386-89
60Clear Cell Adenocarcinoma With a Component of Poorly Differentiated Histology: A Poor Prognostic Subgroup of Ovarian Clear Cell Adenocarcinoma
Yamamoto S, Tsuda H, Shimazaki H, Takano M, Yoshikawa T, Kuzuya K, Tsuda H, Kurachi H, Kigawa J, Kikuchi Y, Sugiyama T, Matsubara O
